First Time Loading...

Pfizer Inc
NYSE:PFE

Watchlist Manager
Pfizer Inc Logo
Pfizer Inc
NYSE:PFE
Watchlist
Price: 25.355 USD 0.38%
Updated: Apr 26, 2024

Intrinsic Value

Pfizer Inc. is a research-based global biopharmaceutical company. [ Read More ]

The intrinsic value of one PFE stock under the Base Case scenario is 21.972 USD. Compared to the current market price of 25.355 USD, Pfizer Inc is Overvalued by 13%.

Key Points:
PFE Intrinsic Value
Base Case
21.972 USD
Overvaluation 13%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Pfizer Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling PFE stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Pfizer Inc

Provide an overview of the primary business activities
of Pfizer Inc.

What unique competitive advantages
does Pfizer Inc hold over its rivals?

What risks and challenges
does Pfizer Inc face in the near future?

Has there been any significant insider trading activity
in Pfizer Inc recently?

Summarize the latest earnings call
of Pfizer Inc.

What significant events have occurred
in Pfizer Inc over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Pfizer Inc.

Provide P/S
for Pfizer Inc.

Provide P/E
for Pfizer Inc.

Provide P/OCF
for Pfizer Inc.

Provide P/FCFE
for Pfizer Inc.

Provide P/B
for Pfizer Inc.

Provide EV/S
for Pfizer Inc.

Provide EV/GP
for Pfizer Inc.

Provide EV/EBITDA
for Pfizer Inc.

Provide EV/EBIT
for Pfizer Inc.

Provide EV/OCF
for Pfizer Inc.

Provide EV/FCFF
for Pfizer Inc.

Provide EV/IC
for Pfizer Inc.

Show me price targets
for Pfizer Inc made by professional analysts.

What are the Revenue projections
for Pfizer Inc?

How accurate were the past Revenue estimates
for Pfizer Inc?

What are the Net Income projections
for Pfizer Inc?

How accurate were the past Net Income estimates
for Pfizer Inc?

What are the EPS projections
for Pfizer Inc?

How accurate were the past EPS estimates
for Pfizer Inc?

What are the EBIT projections
for Pfizer Inc?

How accurate were the past EBIT estimates
for Pfizer Inc?

Compare the revenue forecasts
for Pfizer Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Pfizer Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Pfizer Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Pfizer Inc compared to its peers.

Compare the P/E ratios
of Pfizer Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Pfizer Inc with its peers.

Analyze the financial leverage
of Pfizer Inc compared to its main competitors.

Show all profitability ratios
for Pfizer Inc.

Provide ROE
for Pfizer Inc.

Provide ROA
for Pfizer Inc.

Provide ROIC
for Pfizer Inc.

Provide ROCE
for Pfizer Inc.

Provide Gross Margin
for Pfizer Inc.

Provide Operating Margin
for Pfizer Inc.

Provide Net Margin
for Pfizer Inc.

Provide FCF Margin
for Pfizer Inc.

Show all solvency ratios
for Pfizer Inc.

Provide D/E Ratio
for Pfizer Inc.

Provide D/A Ratio
for Pfizer Inc.

Provide Interest Coverage Ratio
for Pfizer Inc.

Provide Altman Z-Score Ratio
for Pfizer Inc.

Provide Quick Ratio
for Pfizer Inc.

Provide Current Ratio
for Pfizer Inc.

Provide Cash Ratio
for Pfizer Inc.

What is the historical Revenue growth
over the last 5 years for Pfizer Inc?

What is the historical Net Income growth
over the last 5 years for Pfizer Inc?

What is the current Free Cash Flow
of Pfizer Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Pfizer Inc.

Financials

Balance Sheet Decomposition
Pfizer Inc

Current Assets 43.3B
Cash & Short-Term Investments 12.7B
Receivables 15.2B
Other Current Assets 15.5B
Non-Current Assets 183.2B
Long-Term Investments 15.4B
PP&E 18.9B
Intangibles 132.7B
Other Non-Current Assets 16.2B
Current Liabilities 47.8B
Accounts Payable 6.7B
Accrued Liabilities 2.8B
Short-Term Debt 8.1B
Other Current Liabilities 30.2B
Non-Current Liabilities 89.7B
Long-Term Debt 61.5B
Other Non-Current Liabilities 28.2B
Efficiency

Earnings Waterfall
Pfizer Inc

Revenue
58.5B USD
Cost of Revenue
-17.8B USD
Gross Profit
40.7B USD
Operating Expenses
-27.6B USD
Operating Income
13.1B USD
Other Expenses
-11B USD
Net Income
2.1B USD

Free Cash Flow Analysis
Pfizer Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

PFE Profitability Score
Profitability Due Diligence

Pfizer Inc's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

Positive Free Cash Flow
Positive Gross Profit
Positive 3-Year Average ROE
Positive Operating Income
63/100
Profitability
Score

Pfizer Inc's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

PFE Solvency Score
Solvency Due Diligence

Pfizer Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
40/100
Solvency
Score

Pfizer Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PFE Price Targets Summary
Pfizer Inc

Wall Street analysts forecast PFE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PFE is 31.722 USD with a low forecast of 26.26 USD and a high forecast of 47.25 USD.

Lowest
Price Target
26.26 USD
4% Upside
Average
Price Target
31.722 USD
25% Upside
Highest
Price Target
47.25 USD
86% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

PFE Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

PFE Price
Pfizer Inc

1M 1M
-8%
6M 6M
-19%
1Y 1Y
-34%
3Y 3Y
-29%
5Y 5Y
-22%
10Y 10Y
+17%
Annual Price Range
25.355
52w Low
25.26
52w High
40.28
Price Metrics
Average Annual Return 14.34%
Standard Deviation of Annual Returns 30.69%
Max Drawdown -57%
Shares Statistics
Market Capitalization 143.2B USD
Shares Outstanding 5 662 540 000
Percentage of Shares Shorted 1.15%

PFE Return Decomposition
Main factors of price return

What is price return decomposition?

PFE News

Other Videos

Last Important Events
Pfizer Inc

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Pfizer Inc

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Pfizer Inc Logo
Pfizer Inc

Country

United States of America

Industry

Pharmaceuticals

Market Cap

143.2B USD

Dividend Yield

6.38%

Description

Pfizer Inc. is a research-based global biopharmaceutical company. The company is headquartered in New York City, New York and currently employs 79,000 full-time employees. The firm is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The firm offers therapeutic candidates in gastroenterology, dermatology, and cardiology, including etrasimod, an oral, selective sphingosine 1-phosphate (S1P) receptor modulator in development for a range of immuno-inflammatory diseases, including ulcerative colitis, Crohn’s Disease, atopic dermatitis, eosinophilic esophagitis, and alopecia areata. The firm works across markets to develop wellness, prevention, treatments and cures. The company collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. The firm's medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness.

Contact

NEW YORK
New York City
235 E 42nd St
+12125732323.0
https://www.pfizer.com/

IPO

1944-01-17

Employees

79 000

Officers

Chairman of the Board & CEO
Dr. Albert Bourla D.V.M., Ph.D.
Chief Financial Officer & Executive VP
Mr. David M. Denton
Chief Scientific Officer and President of Research & Development
Dr. Mikael Dolsten M.D., Ph.D.
Executive VP & General Counsel
Mr. Douglas M. Lankler
Executive VP & Chief U.S. Commercial Officer
Mr. Aamir Malik
Senior VP, Controller & Principal Accounting Officer
Ms. Jennifer B. Damico
Show More
Executive VP and Chief Digital & Technology Officer
Ms. Lidia L. Fonseca
Chief Investor Relations Officer
Ms. Francesca M. DeMartino
Executive VP and Chief Compliance, Quality & Risk Officer
Mr. Rady A. Johnson
Global Chief Marketing Officer
Mr. Andreas J. Panayiotou
Show Less

See Also

Discover More
What is the Intrinsic Value of one PFE stock?

The intrinsic value of one PFE stock under the Base Case scenario is 21.972 USD.

Is PFE stock undervalued or overvalued?

Compared to the current market price of 25.355 USD, Pfizer Inc is Overvalued by 13%.